|

Rotigotine 4Mg/24Hrs Patch Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • I.R.C.C.S. Fondazione Santa Lucia1

Indications

  • Alzheimer's Disease1
  • Alzheimer Disease1

Other1 trial

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.